Cargando…

Deep learning methods for drug response prediction in cancer: Predominant and emerging trends

Cancer claims millions of lives yearly worldwide. While many therapies have been made available in recent years, by in large cancer remains unsolved. Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Partin, Alexander, Brettin, Thomas S., Zhu, Yitan, Narykov, Oleksandr, Clyde, Austin, Overbeek, Jamie, Stevens, Rick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975164/
https://www.ncbi.nlm.nih.gov/pubmed/36873878
http://dx.doi.org/10.3389/fmed.2023.1086097
_version_ 1784898814587437056
author Partin, Alexander
Brettin, Thomas S.
Zhu, Yitan
Narykov, Oleksandr
Clyde, Austin
Overbeek, Jamie
Stevens, Rick L.
author_facet Partin, Alexander
Brettin, Thomas S.
Zhu, Yitan
Narykov, Oleksandr
Clyde, Austin
Overbeek, Jamie
Stevens, Rick L.
author_sort Partin, Alexander
collection PubMed
description Cancer claims millions of lives yearly worldwide. While many therapies have been made available in recent years, by in large cancer remains unsolved. Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans, ultimately suppressing tumors, alleviating suffering, and prolonging lives of patients. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. These papers investigate diverse data representations, neural network architectures, learning methodologies, and evaluations schemes. However, deciphering promising predominant and emerging trends is difficult due to the variety of explored methods and lack of standardized framework for comparing drug response prediction models. To obtain a comprehensive landscape of deep learning methods, we conducted an extensive search and analysis of deep learning models that predict the response to single drug treatments. A total of 61 deep learning-based models have been curated, and summary plots were generated. Based on the analysis, observable patterns and prevalence of methods have been revealed. This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
format Online
Article
Text
id pubmed-9975164
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99751642023-03-02 Deep learning methods for drug response prediction in cancer: Predominant and emerging trends Partin, Alexander Brettin, Thomas S. Zhu, Yitan Narykov, Oleksandr Clyde, Austin Overbeek, Jamie Stevens, Rick L. Front Med (Lausanne) Medicine Cancer claims millions of lives yearly worldwide. While many therapies have been made available in recent years, by in large cancer remains unsolved. Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans, ultimately suppressing tumors, alleviating suffering, and prolonging lives of patients. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. These papers investigate diverse data representations, neural network architectures, learning methodologies, and evaluations schemes. However, deciphering promising predominant and emerging trends is difficult due to the variety of explored methods and lack of standardized framework for comparing drug response prediction models. To obtain a comprehensive landscape of deep learning methods, we conducted an extensive search and analysis of deep learning models that predict the response to single drug treatments. A total of 61 deep learning-based models have been curated, and summary plots were generated. Based on the analysis, observable patterns and prevalence of methods have been revealed. This review allows to better understand the current state of the field and identify major challenges and promising solution paths. Frontiers Media S.A. 2023-02-15 /pmc/articles/PMC9975164/ /pubmed/36873878 http://dx.doi.org/10.3389/fmed.2023.1086097 Text en Copyright © 2023 Partin, Brettin, Zhu, Narykov, Clyde, Overbeek and Stevens. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Partin, Alexander
Brettin, Thomas S.
Zhu, Yitan
Narykov, Oleksandr
Clyde, Austin
Overbeek, Jamie
Stevens, Rick L.
Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
title Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
title_full Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
title_fullStr Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
title_full_unstemmed Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
title_short Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
title_sort deep learning methods for drug response prediction in cancer: predominant and emerging trends
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975164/
https://www.ncbi.nlm.nih.gov/pubmed/36873878
http://dx.doi.org/10.3389/fmed.2023.1086097
work_keys_str_mv AT partinalexander deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends
AT brettinthomass deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends
AT zhuyitan deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends
AT narykovoleksandr deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends
AT clydeaustin deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends
AT overbeekjamie deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends
AT stevensrickl deeplearningmethodsfordrugresponsepredictionincancerpredominantandemergingtrends